We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · November 22, 2020

Intravitreal Anti-VEGF Injections vs Intravitreal Dexamethasone Injections for Central Retinal Vein Occlusion

The British Journal of Ophthalmology


Additional Info

The British Journal of Ophthalmology
Multicentre Study of 4626 Patients Assesses the Effectiveness, Safety and Burden of Two Categories of Treatments for Central Retinal Vein Occlusion: Intravitreal Anti-Vascular Endothelial Growth Factor Injections and Intravitreal Ozurdex Injections
Br J Ophthalmol 2020 Sep 22;[EPub Ahead of Print], R Gale, C Gill, M Pikoula, AY Lee, RLW Hanson, S Denaxas, C Egan, A Tufail, P Taylor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading